X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-05 | MAIN | Foster Vincent D | Dir | S - Sale | $57.18 | -85,000 | 1,850,296 | -4% | -$4,860,330 | ||||||
2024-12-10 | MAIN | Meserve Nicholas | MD | S - Sale | $55.01 | -9,000 | 86,667 | -9% | -$495,090 | ||||||
2024-03-07 | MAIN | Meserve Nicholas | MD | S - Sale | $45.96 | -6,000 | 83,291 | -7% | -$275,761 | ||||||
| M | 2024-03-01 | MAIN | Beauvais Jason B | EVP, GC, CCO, SECRETARY | S - Sale | $45.57 | -27,500 | 154,187 | -15% | -$1,253,100 | |||||
2023-12-20 | MAIN | Meserve Nicholas | MD | S - Sale | $43.01 | -6,000 | 89,251 | -6% | -$258,084 | ||||||
2023-03-31 | MAIN | Jackson John Earl | Dir | P - Purchase | $39.20 | +3,000 | 62,206 | +5% | +$117,585 | ||||||
| M | 2023-03-29 | MAIN | Beauvais Jason B | EVP, GC, CCO, SECRETARY | S - Sale | $39.44 | -14,919 | 151,918 | -9% | -$588,441 | |||||
2023-03-28 | MAIN | Meserve Nicholas | MD | S - Sale | $39.50 | -3,000 | 80,689 | -4% | -$118,500 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |